Table 1 Characteristics of the studied population (n = 165)
From: Determinants of vascular function in patients with type 2 diabetes
Demographics | |
|---|---|
 Age, years | 66 (40, 80) |
 Female gender, n (%) | 116 (70) |
 Time since diagnosis of diabetes, years | 10 (1, 33) |
 Smoking, n (%) | 28 (17) |
 Hypertension, n (%) | 131 (79) |
 Antihypertensive medications, n (%) | 109 (66) |
  ACE-I/ARBs | 84 (51) |
  Calcium channel blockers | 58 (35) |
  Diuretics | 24 (15) |
  Beta blockers | 13 (8) |
 Hypercholesterolemia, n (%) | 150 (91) |
 Statins, n (%) | 48 (29) |
 Oral antidiabetic medication, n (%) | 129 (78) |
  Sulfonylureas | 98 (59) |
  Metformin | 89 (54) |
 Insulin treatment, n (%) | 36 (22) |
 Body mass index, kg/m2 | 30.1 ± 5.5 |
Laboratory investigations | |
 Fasting glucose, mmoL/L | 9.4 ± 2.7 |
 HbA1c, % | 8.3 ± 1.2 |
 Total cholesterol, mmoL/L | 5.6 ± 1.0 |
 HDL-c, mmoL/L | 1.3 ± 0.3 |
 Triglycerides, mmoL/L | 1.7 ± 0.8 |
 LDL-c, mmoL/L | 3.4 ± 0.9 |
 Creatinine, μmoL/L | 78.7 ± 17.7 |
 Glomerular filtration rate, ml/min/1.73 m2 | 78.1 ± 16.3 |
 High sensitivity C-reactive protein, mg/l | 1.84 (0.31, 9.71) |
 Albumin to Creatinine ratio, mg/mmol | 1.20 (0.18, 34.50) |
 Microalbuminuria, n (%) | 31 (19) |
Vascular measurements | |
 Heart rate, beats/min | 72 ± 11 |
 Systolic blood pressure, mmHg | 146 ± 15 |
 Diastolic blood pressure, mmHg | 78 ± 7 |
 Flow-mediated dilation, % | 1.98 ± 1.66 |
 Nitrate-mediated dilation, % | 10.09 ± 3.84 |
 Carotid-femoral pulse wave velocity, m/sec | 10.2 ± 2.2 |